Literature DB >> 16966850

Use of dilutional ultrasound monitoring to detect changes in recirculation during venovenous extracorporeal membrane oxygenation in swine.

Edward M Darling1, Tracy Crowell, Bruce E Searles.   

Abstract

Since recirculation during venovenous extracorporeal membrane oxygenation (VV ECMO) reduces oxygen delivery to the patient, monitoring recirculation is necessary to guide clinicians in interventions that may reduce recirculation and thereby optimize patient care. The use of dilutional ultrasound may be a clinically practical way to quantify recirculation during VV ECMO. This study evaluates in a swine model of VV ECMO a dilutional ultrasound techniques ability to provide accurate recirculation data under changing conditions. One 16-kg swine was cannulated with a dual-lumen cannula and placed on VV ECMO. Recirculation measured by using blood oxygen saturations (r = S(preox) - SVO2/S(postox) - SVO2) was compared with recirculation measured by a saline dilution ultrasound technique. Dilutional ultrasound was then used to measure changes in baseline recirculation in the face of (a) cannula repositioning and (b) a drug-induced cardiac output change. The comparison of recirculation calculations between the saturation method and dilutional ultrasound were similar at all flow rates measured. The time for results was much faster with the use of dilutional ultrasound. Induction of recirculation changes by repositioning the cannula or changing cardiac output was rapidly detected using dilutional ultrasound and showed significant differences from baseline recirculation. Dilutional ultrasound provides a clinically practical method to quantify and monitor recirculation in VV ECMO applications and may aid in assessing interventions to improve oxygen delivery.

Entities:  

Mesh:

Year:  2006        PMID: 16966850     DOI: 10.1097/01.mat.0000237589.20935.a4

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  7 in total

1.  International conference on pediatric mechanical circulatory support systems and pediatric cardiopulmonary perfusion: outcomes and future directions.

Authors:  Akif Undar
Journal:  ASAIO J       Date:  2008 Mar-Apr       Impact factor: 2.872

2.  Measurements of recirculation during neonatal veno-venous extracorporeal membrane oxygenation: clinical application of the ultrasound dilution technique.

Authors:  David Clements; Johanna Primmer; Pamela Ryman; Bonnie Marr; Bruce Searles; Edward Darling
Journal:  J Extra Corpor Technol       Date:  2008-09

3.  Calculating mixed venous saturation during veno-venous extracorporeal membrane oxygenation.

Authors:  Joshua L Walker; Jonathan Gelfond; Lee Ann Zarzabal; Edward Darling
Journal:  Perfusion       Date:  2009-11-30       Impact factor: 1.972

Review 4.  Adult venovenous extracorporeal membrane oxygenation for severe respiratory failure: Current status and future perspectives.

Authors:  Ayan Sen; Hannelisa E Callisen; Cory M Alwardt; Joel S Larson; Amelia A Lowell; Stacy L Libricz; Pritee Tarwade; Bhavesh M Patel; Harish Ramakrishna
Journal:  Ann Card Anaesth       Date:  2016 Jan-Mar

5.  Nitric Oxide Ventilation Improves Recirculation and Right Ventricular Function During Veno-Venous Extracorporeal Membrane Oxygenation in a COVID-19 Patient.

Authors:  Samuel Heuts; Johannes F Ubben; Vanessa Banks-Gonzales; Jan-Willem Sels; Roberto Lorusso; Walther N K A van Mook; Thijs S R Delnoij
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-10-05       Impact factor: 2.628

6.  Extracorporeal Membrane Oxygenation Blood Flow and Blood Recirculation Compromise Thermodilution-Based Measurements of Cardiac Output.

Authors:  Martin Russ; Elvira Steiner; Willehad Boemke; Thilo Busch; Christoph Melzer-Gartzke; Mahdi Taher; Jenelle Badulak; Steffen Weber-Carstens; Erik R Swenson; Roland C E Francis; Philipp A Pickerodt
Journal:  ASAIO J       Date:  2021-11-27       Impact factor: 3.826

7.  Cannula Design and Recirculation During Venovenous Extracorporeal Membrane Oxygenation.

Authors:  Oscar Palmér; Kenneth Palmér; Jan Hultman; Mikael Broman
Journal:  ASAIO J       Date:  2016 Nov/Dec       Impact factor: 2.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.